Mifegymiso (mifepristone And Misoprostol Tablets) - Updates To Product Monograph And Risk Management Plan
Recall Summary Health Canada has updated the product information and safety procedures for MIFEGYMISO, a medication containing mifepristone and misoprostol used for medical abortion. The updates reflect new risk management requirements to ensure safe use of the medication. This affects all MIFEGYMISO products distributed across Canada.
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2017-11-07
- Status
- Closed
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/508d891f-efa5-4bd6-8f8e-8ead12397457